What Happened?
Cambridge, MA-based Foundation Medicine Promoted Michael Kling as Chief Technology Officer
About the Company
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient`s unique cancer. The company`s clinical assays, FoundationOne for solid tumors and FoundationOne Heme for hematologic malignancies and sarcomas, provide a comprehensive genomic profile to identify the molecular alterations in a patient`s cancer and match them with relevant targeted therapies and clinical trials. Foundation Medicine`s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer.
About the Person
Michael Kling is Chief Technology Officer at Foundation Medicine. Previously, Michael held various senior IT leadership roles in the industry.
Info Source
News
Short Profile